Ruti Aga's Six-Year Ban: How a Forged Prescription Turned a Two-Year Case Into a Career's End

On Thursday night in Chennai I was reading the Athletics Integrity Unit statement on my phone. The line that stopped me wasn't from a medical report. It was this: "an old prescription pad from a former workplace." The doctor whose note Ethiopian marathoner Ruti Aga submitted for her knee treatment did not exist as a doctor. It was a family member with no medical registration, and the clinic printed on the pad did not exist either — the clinic itself wrote to the AIU saying the pad was never theirs.

Three separate lies on one sheet of paper. And those three lies turned a two-year sanction into six.

Aga's name is familiar to anyone who watches the marathon majors. She won the 2026 Tokyo Marathon and finished second at World Marathon Majors three times. That is the record of a 2:18-class runner — the class that does not win you a title in Ethiopia, only a claim on a team place. In March she won a half marathon in China. The sample taken around that race came back positive. She had been provisionally suspended since 10 September, and on Thursday the AIU announced a six-year ban. The race's name, the mark, the depth of the field — none of it is in the report. This is not a performance story.

One technical point needs clearing up, because the early reports got it wrong. Methylprednisolone was described as a "prohibited steroid." That is imprecise. It is a glucocorticoid, class S9 on the WADA Prohibited List, not an anabolic steroid (S1). And S9 is prohibited in-competition only, by injection, oral or rectal route. A therapeutic knee injection given out of competition is entirely legal. The whole case rested not on the choice of drug but on route and timing. On road races the testing window opens at 23:59 the night before, which is why an injection given days earlier still gets caught.

Aga had a genuine defence available, and she destroyed it herself with a fake document. Intra-articular methylprednisolone for knee synovitis is standard sports-medicine practice in distance runners. Real records — date, dose, route, a registered physician's name — would have built a timing and medical-necessity argument, and the sanction could have collapsed to a reprimand. The moment she forged the prescription, she erased her strongest case.

The sanction arithmetic makes this plain. Two years for presence — the standard outcome for a Specified Substance where intent is not proven. Four years for tampering — the Code's standard penalty. Six in total. That sum tells us the panel rejected the no-significant-fault mitigation. Had the two years been cut, the six would never have existed. The backdating to 10 September is no concession either; provisional suspension time counts against the ban, so the athlete gains nothing real.

The four-year tampering charge came from an interview, not from a document alone. Statements given under questioning played a part. Language and translation in AIU interviews with East African athletes is a recurring point of friction, and this case sits squarely in that family.

Then there is the part the report barely touches — the medical infrastructure. No registered team physician appears anywhere near Aga. No Therapeutic Use Exemption application. A knee injection, and paperwork arranged from inside the family. The decision to forge a prescription tells you that no credentialed medical team was present.

My own experience surfaces here. In February 2026, in the 400m hurdles final at the Jawaharlal Nehru Stadium in Chennai, I clipped the seventh hurdle, tore my right hamstring, finished sixth in 54.9 — and that was the last race of the career, with no Railways or Police quota waiting at the end of it. That year taught me that injury is not only a bodily event; it is an audit of your economic structure. For a runner holding a sports-quota job, a knee is a medical problem. For a runner holding only appearance fees, a knee is an income crisis. And decisions taken inside an income crisis are rarely correct.

This is where China's label races enter. That March half marathon belongs to the income tier where East African marathoners survive between majors: high appearance fees, few races, low risk. The same tier is now the AIU's highest-yield testing ground. The appearance-fee economy and the testing economy are colliding in the same races, and that collision will only sharpen.

And the effect on Ethiopian depth? A 32-year-old with no global championship medal leaving the sport changes nothing in selection arithmetic. In a country where even a 2:18 performer is not assured of a team place, a ban does not touch national capacity at all. Six years on she will be nearly 38, and a return at that age is practically closed.

Here is the angle that troubles me most. Six years fell on a drug with no proven endurance benefit. A glucocorticoid reduces pain and swelling; it does not build muscle. The severity came from the paper lie, not the pharmacology — technically correct. The result, though, is that a systemic failure was converted into an individual sentence. The adviser, agent or coach who helped prepare or accepted that forged prescription is named nowhere in the statement. The AIU cited only the family member. The athlete serves the whole sentence; the network stands outside it. Until the informal medical networks operating inside training clusters face action, the next Aga will forge the same prescription again.

The 2026 Tokyo title stays in the record — the violation is anchored to the March race, and the report does not state the scope of disqualification. The question that remains: will the AIU verify documents next time, or the system in which an injured runner has nobody to write her a legitimate prescription?